Directors & dealings data is unavailable for this security.
Directors & Officers
Click or tap a row for biographies
Name | Title | Compensation | Age | Officer since |
---|---|---|---|---|
Wayne Pisano | Chairman of the Board, Interim Chief Executive Officer | 121.90kCAD | 69 | 2024 |
Kirk Look | Chief Financial Officer | 671.50kCAD | -- | 2012 |
Andrew Guttadauro | Global Head of Business Development, President, Oncolytics Biotech (U.S.) Inc. | 606.06kCAD | -- | 2017 |
Allison Hagerman | Vice President - Product Development | 520.71kCAD | -- | 2010 |
Thomas Heineman | Chief Medical Officer of Oncolytics Biotech (U.S.) | 828.00kCAD | -- | 2020 |